Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Randomized Controlled Trial1
- Clinical Study1
- Comparative Study1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Br J Ophthalmol1
Search Results
Sort by
- BookMaria Dorobanţu, Frank Ruschitzka, Marco Metra, editors.Contents:
Evolving concepts on the basic mechanisms of heart failure
Assessment of left ventricular systolic and diastolic dysfunction
Right ventricular dysfunction in heart failure
The role of atrial functional assessment in heart failure
Assessment of secondary mitral regurgitation
Assessment of left ventricular contractile reserve in heart failure
Role of cardiac magnetic resonance imaging in heart failure
The evolving role of multimodality imaging in heart failure
Contemporary pharmacological treatment of heart failure
Myocardial revascularization in heart failure
Approach to arrhythmia in heart failure
Implantable defibrillator therapy
Cardiac resynchronization therapy
Mechanical circulatory support
Cell and gene therapy in heart failure
Valvular Surgery in Heart Failure
Percutaneous Valvular Therapies in Heart Failure
Pretransplant evaluation
Strategies for improving outcomes in heart transplantation
Heart failure and hypertension
Right heart failure
Acute heart failure
Heart failure in oncologic patients
Iron Deficiency in Heart Failure
The kidney and electrolyte imbalances in heart failure
Prognostic factors and risk scores in heart failure
Rehabilitation therapy in patients with heart failure. .Digital Access Springer 2016 - ArticleMacdonald MJ, Gore SM, Cullen PM, Phillips CI.Br J Ophthalmol. 1977 May;61(5):345-8.The ocular hypotensive effect of single oral doses of (a) atenolol (50 mg), (b) acetazolamide (500 mg), (c) atenolol (50 mg) and acetazolamide (500 mg) in combination, and (d) vehicle (inert tablets) were compared in 8 patients with glaucoma. In this single-dose, double-masked trial the combination was observed as most effective in reducing ocular tension. Both the combination and atenolol performed markedly better than vehicle. That acetazolamide did not reduce ocular tension significantly more than vehicle is probably explained by relatively low initial ocular tensions. There was no evidence of interaction between atenolol and acetazolamide in this study. Acetazolamide probably remains the first-choice oral medication for glaucoma. It is cautiously suggested that beta-blocking drugs may have a future therapeutic role, but longer-term studies on larger numbers will be required to establish this.